The project received a grant from the Sten K. Johnsson Foundation in 2015. Since then, the following has happened: 1) a needle prototype has been developed with JOIN in Lund. 2) A study of the needle at the Centre of Bacteriology at Lund University has shown that: a) the needle works b) it provides temperature-sensitive killing of bacteria c) it has a very good effect on E. coli, which is the bacterium that usually causes clinical infection. The needle works well in a laboratory environment. The goal is to reduce the number of infections associated with prostate biopsies. As a side effect of safer biopsies one can be more liberal with conducting biopsies and logically detect more prostate cancer than before. The technique should also reduce bleeding after the biopsy.
Menu